Global Pertuzumab Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pertuzumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pertuzumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pertuzumab by Country/Region, 2017, 2022 & 2028

2.2 Pertuzumab Segment by Type

2.2.1 Human Source

2.2.2 Animal Source

2.3 Pertuzumab Sales by Type

2.3.1 Global Pertuzumab Sales Market Share by Type (2017-2022)

2.3.2 Global Pertuzumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pertuzumab Sale Price by Type (2017-2022)

2.4 Pertuzumab Segment by Application

2.4.1 Hospital

2.4.2 Medical Center

2.5 Pertuzumab Sales by Application

2.5.1 Global Pertuzumab Sale Market Share by Application (2017-2022)

2.5.2 Global Pertuzumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pertuzumab Sale Price by Application (2017-2022)

3 Global Pertuzumab by Company

3.1 Global Pertuzumab Breakdown Data by Company

3.1.1 Global Pertuzumab Annual Sales by Company (2020-2022)

3.1.2 Global Pertuzumab Sales Market Share by Company (2020-2022)

3.2 Global Pertuzumab Annual Revenue by Company (2020-2022)

3.2.1 Global Pertuzumab Revenue by Company (2020-2022)

3.2.2 Global Pertuzumab Revenue Market Share by Company (2020-2022)

3.3 Global Pertuzumab Sale Price by Company

3.4 Key Manufacturers Pertuzumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pertuzumab Product Location Distribution

3.4.2 Players Pertuzumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pertuzumab by Geographic Region

4.1 World Historic Pertuzumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Pertuzumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pertuzumab Annual Revenue by Geographic Region

4.2 World Historic Pertuzumab Market Size by Country/Region (2017-2022)

4.2.1 Global Pertuzumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pertuzumab Annual Revenue by Country/Region

4.3 Americas Pertuzumab Sales Growth

4.4 APAC Pertuzumab Sales Growth

4.5 Europe Pertuzumab Sales Growth

4.6 Middle East & Africa Pertuzumab Sales Growth

5 Americas

5.1 Americas Pertuzumab Sales by Country

5.1.1 Americas Pertuzumab Sales by Country (2017-2022)

5.1.2 Americas Pertuzumab Revenue by Country (2017-2022)

5.2 Americas Pertuzumab Sales by Type

5.3 Americas Pertuzumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pertuzumab Sales by Region

6.1.1 APAC Pertuzumab Sales by Region (2017-2022)

6.1.2 APAC Pertuzumab Revenue by Region (2017-2022)

6.2 APAC Pertuzumab Sales by Type

6.3 APAC Pertuzumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pertuzumab by Country

7.1.1 Europe Pertuzumab Sales by Country (2017-2022)

7.1.2 Europe Pertuzumab Revenue by Country (2017-2022)

7.2 Europe Pertuzumab Sales by Type

7.3 Europe Pertuzumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pertuzumab by Country

8.1.1 Middle East & Africa Pertuzumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pertuzumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Pertuzumab Sales by Type

8.3 Middle East & Africa Pertuzumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pertuzumab

10.3 Manufacturing Process Analysis of Pertuzumab

10.4 Industry Chain Structure of Pertuzumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pertuzumab Distributors

11.3 Pertuzumab Customer

12 World Forecast Review for Pertuzumab by Geographic Region

12.1 Global Pertuzumab Market Size Forecast by Region

12.1.1 Global Pertuzumab Forecast by Region (2023-2028)

12.1.2 Global Pertuzumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pertuzumab Forecast by Type

12.7 Global Pertuzumab Forecast by Application

13 Key Players Analysis

13.1 Novartis AG

13.1.1 Novartis AG Company Information

13.1.2 Novartis AG Pertuzumab Product Offered

13.1.3 Novartis AG Pertuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis AG Main Business Overview

13.1.5 Novartis AG Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Pertuzumab Product Offered

13.2.3 Pfizer Pertuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Abnova Corporation

13.3.1 Abnova Corporation Company Information

13.3.2 Abnova Corporation Pertuzumab Product Offered

13.3.3 Abnova Corporation Pertuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Abnova Corporation Main Business Overview

13.3.5 Abnova Corporation Latest Developments

13.4 InvivoGen

13.4.1 InvivoGen Company Information

13.4.2 InvivoGen Pertuzumab Product Offered

13.4.3 InvivoGen Pertuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 InvivoGen Main Business Overview

13.4.5 InvivoGen Latest Developments

13.5 Celltrion

13.5.1 Celltrion Company Information

13.5.2 Celltrion Pertuzumab Product Offered

13.5.3 Celltrion Pertuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Celltrion Main Business Overview

13.5.5 Celltrion Latest Developments

13.6 Biocon Limited

13.6.1 Biocon Limited Company Information

13.6.2 Biocon Limited Pertuzumab Product Offered

13.6.3 Biocon Limited Pertuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Biocon Limited Main Business Overview

13.6.5 Biocon Limited Latest Developments

13.7 Bio-Techne

13.7.1 Bio-Techne Company Information

13.7.2 Bio-Techne Pertuzumab Product Offered

13.7.3 Bio-Techne Pertuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bio-Techne Main Business Overview

13.7.5 Bio-Techne Latest Developments

14 Research Findings and Conclusion

Table 1. Pertuzumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pertuzumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Human Source

Table 4. Major Players of Animal Source

Table 5. Global Pertuzumab Sales by Type (2017-2022) & (MT)

Table 6. Global Pertuzumab Sales Market Share by Type (2017-2022)

Table 7. Global Pertuzumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Pertuzumab Revenue Market Share by Type (2017-2022)

Table 9. Global Pertuzumab Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Pertuzumab Sales by Application (2017-2022) & (MT)

Table 11. Global Pertuzumab Sales Market Share by Application (2017-2022)

Table 12. Global Pertuzumab Revenue by Application (2017-2022)

Table 13. Global Pertuzumab Revenue Market Share by Application (2017-2022)

Table 14. Global Pertuzumab Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Pertuzumab Sales by Company (2020-2022) & (MT)

Table 16. Global Pertuzumab Sales Market Share by Company (2020-2022)

Table 17. Global Pertuzumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Pertuzumab Revenue Market Share by Company (2020-2022)

Table 19. Global Pertuzumab Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Pertuzumab Producing Area Distribution and Sales Area

Table 21. Players Pertuzumab Products Offered

Table 22. Pertuzumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Pertuzumab Sales by Geographic Region (2017-2022) & (MT)

Table 26. Global Pertuzumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Pertuzumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Pertuzumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Pertuzumab Sales by Country/Region (2017-2022) & (MT)

Table 30. Global Pertuzumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Pertuzumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Pertuzumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Pertuzumab Sales by Country (2017-2022) & (MT)

Table 34. Americas Pertuzumab Sales Market Share by Country (2017-2022)

Table 35. Americas Pertuzumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Pertuzumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Pertuzumab Sales by Type (2017-2022) & (MT)

Table 38. Americas Pertuzumab Sales Market Share by Type (2017-2022)

Table 39. Americas Pertuzumab Sales by Application (2017-2022) & (MT)

Table 40. Americas Pertuzumab Sales Market Share by Application (2017-2022)

Table 41. APAC Pertuzumab Sales by Region (2017-2022) & (MT)

Table 42. APAC Pertuzumab Sales Market Share by Region (2017-2022)

Table 43. APAC Pertuzumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Pertuzumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Pertuzumab Sales by Type (2017-2022) & (MT)

Table 46. APAC Pertuzumab Sales Market Share by Type (2017-2022)

Table 47. APAC Pertuzumab Sales by Application (2017-2022) & (MT)

Table 48. APAC Pertuzumab Sales Market Share by Application (2017-2022)

Table 49. Europe Pertuzumab Sales by Country (2017-2022) & (MT)

Table 50. Europe Pertuzumab Sales Market Share by Country (2017-2022)

Table 51. Europe Pertuzumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Pertuzumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Pertuzumab Sales by Type (2017-2022) & (MT)

Table 54. Europe Pertuzumab Sales Market Share by Type (2017-2022)

Table 55. Europe Pertuzumab Sales by Application (2017-2022) & (MT)

Table 56. Europe Pertuzumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Pertuzumab Sales by Country (2017-2022) & (MT)

Table 58. Middle East & Africa Pertuzumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Pertuzumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Pertuzumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Pertuzumab Sales by Type (2017-2022) & (MT)

Table 62. Middle East & Africa Pertuzumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Pertuzumab Sales by Application (2017-2022) & (MT)

Table 64. Middle East & Africa Pertuzumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Pertuzumab

Table 66. Key Market Challenges & Risks of Pertuzumab

Table 67. Key Industry Trends of Pertuzumab

Table 68. Pertuzumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Pertuzumab Distributors List

Table 71. Pertuzumab Customer List

Table 72. Global Pertuzumab Sales Forecast by Region (2023-2028) & (MT)

Table 73. Global Pertuzumab Sales Market Forecast by Region

Table 74. Global Pertuzumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Pertuzumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Pertuzumab Sales Forecast by Country (2023-2028) & (MT)

Table 77. Americas Pertuzumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Pertuzumab Sales Forecast by Region (2023-2028) & (MT)

Table 79. APAC Pertuzumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Pertuzumab Sales Forecast by Country (2023-2028) & (MT)

Table 81. Europe Pertuzumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Pertuzumab Sales Forecast by Country (2023-2028) & (MT)

Table 83. Middle East & Africa Pertuzumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Pertuzumab Sales Forecast by Type (2023-2028) & (MT)

Table 85. Global Pertuzumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Pertuzumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Pertuzumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Pertuzumab Sales Forecast by Application (2023-2028) & (MT)

Table 89. Global Pertuzumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Pertuzumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Pertuzumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novartis AG Basic Information, Pertuzumab Manufacturing Base, Sales Area and Its Competitors

Table 93. Novartis AG Pertuzumab Product Offered

Table 94. Novartis AG Pertuzumab Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. Novartis AG Main Business

Table 96. Novartis AG Latest Developments

Table 97. Pfizer Basic Information, Pertuzumab Manufacturing Base, Sales Area and Its Competitors

Table 98. Pfizer Pertuzumab Product Offered

Table 99. Pfizer Pertuzumab Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Pfizer Main Business

Table 101. Pfizer Latest Developments

Table 102. Abnova Corporation Basic Information, Pertuzumab Manufacturing Base, Sales Area and Its Competitors

Table 103. Abnova Corporation Pertuzumab Product Offered

Table 104. Abnova Corporation Pertuzumab Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Abnova Corporation Main Business

Table 106. Abnova Corporation Latest Developments

Table 107. InvivoGen Basic Information, Pertuzumab Manufacturing Base, Sales Area and Its Competitors

Table 108. InvivoGen Pertuzumab Product Offered

Table 109. InvivoGen Pertuzumab Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. InvivoGen Main Business

Table 111. InvivoGen Latest Developments

Table 112. Celltrion Basic Information, Pertuzumab Manufacturing Base, Sales Area and Its Competitors

Table 113. Celltrion Pertuzumab Product Offered

Table 114. Celltrion Pertuzumab Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. Celltrion Main Business

Table 116. Celltrion Latest Developments

Table 117. Biocon Limited Basic Information, Pertuzumab Manufacturing Base, Sales Area and Its Competitors

Table 118. Biocon Limited Pertuzumab Product Offered

Table 119. Biocon Limited Pertuzumab Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Biocon Limited Main Business

Table 121. Biocon Limited Latest Developments

Table 122. Bio-Techne Basic Information, Pertuzumab Manufacturing Base, Sales Area and Its Competitors

Table 123. Bio-Techne Pertuzumab Product Offered

Table 124. Bio-Techne Pertuzumab Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. Bio-Techne Main Business

Table 126. Bio-Techne Latest Developments

List of Figures

Figure 1. Picture of Pertuzumab

Figure 2. Pertuzumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pertuzumab Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Pertuzumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pertuzumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Human Source

Figure 10. Product Picture of Animal Source

Figure 11. Global Pertuzumab Sales Market Share by Type in 2021

Figure 12. Global Pertuzumab Revenue Market Share by Type (2017-2022)

Figure 13. Pertuzumab Consumed in Hospital

Figure 14. Global Pertuzumab Market: Hospital (2017-2022) & (MT)

Figure 15. Pertuzumab Consumed in Medical Center

Figure 16. Global Pertuzumab Market: Medical Center (2017-2022) & (MT)

Figure 17. Global Pertuzumab Sales Market Share by Application (2017-2022)

Figure 18. Global Pertuzumab Revenue Market Share by Application in 2021

Figure 19. Pertuzumab Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Pertuzumab Revenue Market Share by Company in 2021

Figure 21. Global Pertuzumab Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Pertuzumab Revenue Market Share by Geographic Region in 2021

Figure 23. Global Pertuzumab Sales Market Share by Region (2017-2022)

Figure 24. Global Pertuzumab Revenue Market Share by Country/Region in 2021

Figure 25. Americas Pertuzumab Sales 2017-2022 (MT)

Figure 26. Americas Pertuzumab Revenue 2017-2022 ($ Millions)

Figure 27. APAC Pertuzumab Sales 2017-2022 (MT)

Figure 28. APAC Pertuzumab Revenue 2017-2022 ($ Millions)

Figure 29. Europe Pertuzumab Sales 2017-2022 (MT)

Figure 30. Europe Pertuzumab Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Pertuzumab Sales 2017-2022 (MT)

Figure 32. Middle East & Africa Pertuzumab Revenue 2017-2022 ($ Millions)

Figure 33. Americas Pertuzumab Sales Market Share by Country in 2021

Figure 34. Americas Pertuzumab Revenue Market Share by Country in 2021

Figure 35. United States Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Pertuzumab Sales Market Share by Region in 2021

Figure 40. APAC Pertuzumab Revenue Market Share by Regions in 2021

Figure 41. China Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Pertuzumab Sales Market Share by Country in 2021

Figure 48. Europe Pertuzumab Revenue Market Share by Country in 2021

Figure 49. Germany Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Pertuzumab Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Pertuzumab Revenue Market Share by Country in 2021

Figure 56. Egypt Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Pertuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Pertuzumab in 2021

Figure 62. Manufacturing Process Analysis of Pertuzumab

Figure 63. Industry Chain Structure of Pertuzumab

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles